Intranasal metformin produced higher metformin concentrations in the hippocampus and lowered plasma concentrations, which enhanced insulin sensitivity more than oral treatment in mice with intracerebroventricular-streptozotocin (ICV-STZ)-induced AD (Kazkayasi et al., 2022). This evidence concerns the gene INS and Alzheimer disease.